SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

Chainlink is seeing heightened interest amid broader market volatility, with the community polarized between those focusing on its fundamental role as critical infrastructure for tokenized real-world assets and those frustrated by its recent price performance. While traders debate its long-term potential compared to other projects, sentiment is heavily influenced by expectations regarding regulatory clarity and institutional adoption of blockchain financial systems.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is surging amid a breakout rally that has pushed the price to new highs, with the community frequently labeling the asset as a more advanced, private version of Bitcoin. Discussion is dominated by bullish momentum, significant short covering, and expectations for further gains, though some traders remain skeptical and warn of potential volatility or corrections.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is trending following its third-quarter earnings report, where a revenue beat was overshadowed by weaker-than-expected fourth-quarter earnings guidance. Traders are debating the stock's future amid management's warnings of rising semiconductor input costs and an accelerating decline in revenue from Apple modems.

Newsmax Inc. is a holding company, which engages in television broadcasting and multi-platform content publishing that produces original news and editorial content for consumers through various media outlets, including TV new channels, digital and print publications. It operates through the Broadcasting and Digital Segments. The Broadcasting segment produces and licenses news, business news and lifestyle content for distribution through both MVPDs and free OTT streaming platforms. The Digital segment is composed of Newsmax.com and affiliated websites. The company was founded by Christopher Ruddy in 1998 and is headquartered in Boca Raton, FL.

Newsmax Inc. - Ordinary Shares - Class B

Newsmax Inc

NMAX is experiencing significant volatility driven by intense retail interest and momentum trading, with many participants speculating on the potential for a short squeeze similar to other volatile market movers. While some traders highlight the company's recent earnings beat and expanded international licensing as fundamental support, others remain skeptical, characterizing the price action as an unsupported pump-and-dump cycle.

XYO is the original and one of the largest Decentralized Physical Infrastructure Networks (DePIN), boasting over 10 million nodes and consistently leading DePIN in both scale and revenue generation. Launching its Mainnet ahead of any other DePIN, XYO specializes in collecting and validating real-world data, bridging it seamlessly to Web3 and Web2 companies across AI, geolocation, and other critical data sectors. At the core of XYO are Proof of Location and Proof of Origin technologies, enabling accurate validation of real-world data for innovative use cases such as Real-World Asset (RWA) tracking, DePIN applications, real-world gaming, and treasure hunts. Recently, XYO expanded its ecosystem by launching the XYO Layer One blockchain, purpose-built to support the intensive data demands of DePIN, RWA, AI, and similar data-driven industries. XYO employs a unique dual-token model: XYO Token: An externally traded token supporting the DePIN ecosystem, rewards, staking, and governance, enhancing overall ecosystem value and scarcity.   XL1 Token: Internal to the XYO Layer One blockchain, facilitating transactions, gas fees, and other blockchain-specific use cases. The dual-token economics are strategically designed to increase scarcity and promote sustainable growth. The XYO token is available on major exchanges, including Coinbase. The XL1 token will launch publicly later in 2025. To accelerate network adoption and growth, XYO created the popular COIN app. Beyond the XYO Foundation, the team founded the U.S.-based, for-profit entity XY Labs Inc., notable as the first U.S. crypto company qualified by the SEC for a Regulation A offering, permitting share sales to both accredited and non-accredited investors. XY Labs further stands out as one of the pioneering U.S. companies to tokenize and publicly list its shares. These tokenized shares trade as $XYLB on the tZERO ATS, positioning XY Labs prominently in the growing wave of Real-World Asset (RWA) tokenization.

XYO Network

Conversation surrounding XYO is fragmented, primarily focusing on skepticism regarding its price performance, allegations of pump-and-dump behavior, and frustration with the company's dual-token model involving XL1. While some traders continue to express optimism based on the project's long-term utility in the DePIN sector, a vocal segment of the community remains highly critical, citing repeated failed price targets and a lack of sustained gains.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in Sarnia, Canada.

Aduro Clean Technologies Inc

Aduro Clean Technologies is seeing active discussion as investors focus on recent developments, including an MOU for synthetic turf recycling and progress in continuous-flow testing for paraffinic crude, while debating the company's timeline for commercialization and the underlying economics of its Hydrochemolytic technology. Many in the community remain bullish on the stock's long-term potential as a circular economy play, often citing institutional accumulation, while skeptics point to the lack of proven commercial revenue after years of development.

Groupon, Inc. engages in the global scaled two-sided marketplace that connects consumers to merchants. It operates through the North America and International geographical segments. The company was founded by Andrew D. Mason, Eric Paul Lefkofsky, and Bradley A. Keywell in October 2008 and is headquartered in Chicago, IL.

Groupon Inc

The community is focused on the potential for a short squeeze, citing high short interest as a percentage of the float and a tightly held supply due to institutional ownership and share buybacks. Traders are closely monitoring key support levels and options activity, debating whether the stock's recent price action constitutes a mechanical squeeze setup or a standard consolidation.

TOSHI

TOSHI is trending as traders speculate on a potential price breakout, citing technical chart patterns like pennants and wedges, alongside expectations of a short squeeze. Community members are actively accumulating, pointing to historical support levels and expressing optimism for future exchange listings or ecosystem-related catalysts.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is trending amid renewed M&A speculation and analyst upgrades, with traders reacting to potential buyout interest following recent competitor acquisitions in the rare disease space. While sentiment is bolstered by these reports, significant frustration remains among retail investors regarding the stock's long-term volatility and perceived market manipulation.

Direxion Shares ETF Trust - Direxion Daily TSLA Bull 2X ETF

Direxion Daily TSLA Bull 2X Shares

TSLL is receiving attention as traders debate the viability of holding a leveraged ETF long-term versus day trading it to capitalize on TSLA's volatile price action, with many discussing the impact of options gamma and algorithmic trading on the instrument's recent swings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Canaccord just upgraded Seres Therapeutics with a $22 price target.  
With the stock currently at $8.63, that’s a potential upside of roughly +155% (Ser 155 🙃)
But the upgrade isn’t the only thing catching attention. With Seres’ assets, its strategic positioning, and growing interest from larger players in the microbiome space, a buyout scenario is becoming increasingly realistic. The valuation gap is huge, and Seres could be a fast, strategic acquisition for any pharma looking to strengthen its pipeline.
This upgrade might be the first real signal.
$MCRB $MRK $NSRGY #Canaccord #BuyoutPotential

carlos_b_a

Neptune

Rolf Wollesen

coreholder

HeadHunter

Christian Woessner

James Cacciabeve

$MCRB The same guy that had a $10 dollar price target in August 2024. That&#39;s $200 dollar post split!!! What a joke! A 90% downgrade since August 2024 John?

StockTwits Web

Roel

StockTwits for iOS

Seres Therapeutics Inc

Merck & Co Inc

Nestle SA ADR

Canaccord just upgraded Seres Therapeutics with a $22 price target.  
With the stock currently at $8.63, that’s a potential upside of roughly +155% (Ser 155 🙃)
But the upgrade isn’t the only thing catching attention. With Seres’ assets, its strategic positioning, and growing interest from larger players in the microbiome space, a buyout scenario is becoming increasingly realistic. The valuation gap is huge, and Seres could be a fast, strategic acquisition for any pharma looking to strengthen its pipeline.
This upgrade might be the first real signal.
